Antibiotics 6108 Al9 B, C and D, a new series of analogues of rosaramicin, were found together with rosaramicin, juvenimicin A4 and M-4365 Ax from the cultured broth of strain BA06108which was assigned to be a newspecies of Micromonospora. 6108Ax and C showedinhibitory activity against Gram-positive and someGram-negativebacteria as potent as rosaramicin and exhibited low acute toxicity in mice. However, 6108 B showed less potent antimicrobial activity and 6108 D showed higher toxicity than those two antibiotics.
In the course of our screening program for a new macrolide antibiotic which is active against both Gram-positive and Gram-negative bacteria, a strain BA06108was found to produce macrolide antibiotics consisting of seven active components, designated 6108 A1^A4, B, C and D. 6108 Al5 6108 B, 6108 C and 6108 D were found to be novel analogues of rosaramicin which are differentiated at the C-18 position, while 6108 A2, A* and A4 were identical with iuvenimicin AA1>2), rosaramicin3)4), and M-4365 Ai5>6). respectively ( Fig. 1 ). This paper describes the taxonomy of the producing strain, fermentation, isolation, and physico-chemical and biological properties of components A1? B, C and D. The structural elucidation of these compoundsare described in an accompanying paper7).
Taxonomyof Producing Organism
Strain No. BA06108was isolated from a soil sample collected in Toyota City, Aichi Prefecture, Japan.
Vegetative mycelia were well developed and branched on agar medium, but aerial mycelium was not formed. No fragmentation of substrate mycelium was observed on agar medium. A single spore was produced on the tip of a short sporophore branching from the vegetative mycelia. This spore was 0.8~1.2^m i.d. and spherical to oval in shape.
The spore surface showed a warty-like structure (Fig. 2) . The abundant spore layer was formed on organic agar media.
The cultural characteristics of strain BA06108 on various media are given in Table 1 . The strain showed good or moderate growth on the organic media, but poor or very poor growth on the synthetic media. The vegetative myceliumis pale orange to pale brownon the organic mediaand a wine red soluble pigment was observed on some of the organic media. Physiological characteristics and utilization Bar represents: 2 /iin. AUG. 1990 of carbon sources of strain BA06108are given in Tables 2 and 3 , respectively. Only glucose was utilized well for growth, and the other carbon sources were not utilized. 
Fermentation
The production ratio of new analogues during fermentation differed markedly depending upon the Table 4 produced 6108 Ax and B, while in the ST-7 medium 6108 B, C and D were produced. Production of 6108 complex was carried out in a 200-liter fermentation tank. The titer of each component in the fermentation broths was determined by HPLCanalysis.
Isolation
Components Al9 B, A2, A3 and A4 were isolated from the fermentation broth (110 liters) cultured in BE-2 medium. The cultured broth was mixed with filter aid and adjusted to pH9.0 and filtered. The broth filtrate was adsorbed on Diaion HP-20resin and after the resin was washed first with water, then with 30%aqueous methanol, the active components were eluted with 80%aqueous acetone. The eluate was concentrated in vacuo, adjusted to pH 9.5, and then extracted with ethyl acetate. The ethyl acetate extract containing components of 6108 A group was concentrated in vacuo to dryness. The residue was subjected to silica gel column chromatography and was separated into four components, Ax, A2, A3 and A4. Each fraction was concentrated in vacuo to dryness and was purified by preparative reverse phase HPLC.ComponentB contained in the water layer of ethyl acetate extraction was extracted with butanol and then purified by silica gel column chromatography, Toyopearl HW-40column chromatography and preparative reverse phase HPLC. Thirty six mg of component A1? 141 mg of B, 274mg of A2, 155mg of A3 and 44mg of A4 were obtained, respectively. Components C and D were isolated from the fermentation broth (1 10 liters) cultured in ST-7 medium. 6108 A group and D were extracted with ethyl acetate, and after back-extraction with hydrochloric acid (pH 3), active substances were reextracted with ethyl acetate at pH9.5. ComponentD was purified by silica gel column chromatography and preparative reverse phase HPLC,to yield 51 mg of component D. ComponentsB and C from aqueous layer of ethyl acetate extraction were extracted with butanol and subjected to silica gel column chromatography. The isolation of component C from B was performed by preparative reverse phase HPLCand provided 81 mg of C. Components A2, A3 and A4 were identical with juvenimicin A41>2), rosaramicin3>4) and M-4365 A^'6*, respectively, by direct comparison with authentic samples by HPLCand TLC. Table 5 compared with those ofrosaramicin. It is noteworthy that components B and C are soluble in water, different from usual macrolides including rosaramicin.
Stabilities of components Al9 C and D were examined in various pH solutions at 37°C (Fig. 3) . Compound Ax was labile at pH's below 7.0, especially at pH 1.5, and was decomposed gradually into rosaramicin and acetohydrazide. CompoundC was also decomposed at pH 5.0 producing some amount of rosaramicin and cysteine. Coexistence of ten equimolar acetohydrazide or cysteine improved the stability of compound A1 or C, respectively. Compound D was stable under conditions tested.
Biological Properties The antimicrobial activity (MIC) of components Al9 B, C and D compared with rosaramicin and erythromycin A is shown in Table 6 . CompoundsA1 and C were equally active to rosaramicin against Gram-positive bacteria and Gram-negative bacteria and showed higher activity than erythromycin A against Gram-negative bacteria and Campylobacter coli. CompoundD was two to four times less active than rosaramicin. CompoundB showed weak antimicrobial activity. The acute toxicity of components Al9 C and D as well as rosaramicin and erythromycin A was tested by intraperitoneal and oral administration to mice (Table 7) . Compounds Kx and C were less toxic than rosaramicin and erythromycin A. Onthe other hand, the toxicity of D was higher than those of rosaramicin and erythromycin A.
Results of mouse protective effect of components Ax and C against Staphylococcus aureus 4970 infection comparing rosaramicin, josamycin and erythromycin A are shown in Table 8 . CompoundAx was as active as rosaramicin, josamycin and erythromycin A. However,compoundC was significantly less active than rosaramicin, josamycin and erythromycin A. the strongest antimicrobial activity among5 compounds tested. CompoundB having a carboxy moiety showed weak activity. Both juvenimicin A4 having a hydroxymethyl moiety and M-4365 At carrying methyl moiety displayed intermediate activity.
It is likely that components of At and C show antimicrobial activity by conversion to rosaramicin, because they easily dissociate to rosaramicin depending on pH. However, the acute toxicity and the mouse protection effect of components Ax and C showed different values from those of rosaramicin. These differences maydepend on their conversion rate to rosaramicin in mice.
Experimental

General Method
UVand IR spectra were recorded on a Shimadzu UV-250spectrophotometer and a Jasco IR-810 IR spectrophotometer, respectively. MP's were measured with a Shibata Model 5227-01. Optical rotations were measured with a Jasco DIP-360 polarimeter. MSspectra were taken on a Nihon Denshi JMS-DX 300/JMA-DA 500 mass spectrometer. NMR spectra were recorded on a Varian VXR 300 NMR spectrometer for *H NMRat 300 MHzand 13C NMRat 75 MHz.
Taxonomic Studies of the Producing Organism Most of the procedures used in the study were in accordance with the methods adopted by the International Streptomyces Project (ISP)14). Additional media recommended by Waksman15) were also used. All the various media were inoculated with a washed spore suspension grown for 7 days at 27°C in a yeast extract-malt extract agar medium. Color names were based on the Color Standard of Nihon Shikisai, Co., Ltd.f. Utilization of carbon sources was tested by growth on Pridham and Gottlieb medium containing 1.0% each carbon source. Spore and mycelial morphologies of the cultures were observed by both light microscopy and scanning electron microscopy. flow rate, 4.0ml/minute, temperature, 40°C; detection, UV200-400 nm. Apparatus: HPLC system, TRI ROTAR-SR2 (Jasco); detector, MCPD-350 (Otsuka Electronics Co., Ltd.).
Isolation and Purification of CompoundsAx and B
The fermentation broth (110 liters) cultured in BE-2 medium was treated with Hyflo Super-Cel (Johns-Manville Sales Co.) (3 kg), adjusted to pH9.5 with 10% NaOHand then filtered. Diaion HP-20 (Mitsubishi Chemical Industries Ltd.) (4 liters) was added to the broth filtrate (100-liter) which was stirred for 2 hours, collected by filtration and packed into the column. The column was washed with water (18 liters) and 25% aqueous MeOH (8 liters) . The active components were eluted with 80% aqueous MeOH. The eluate was concentrated in vacuo and the aqueous residue was adjusted to pH9.5 with 5%NaOH and extracted twice with equal volume of EtOAc. The extract was evaporated in vacuo to give an oily residue. The residue was dissolved in a small amount of CHC13and applied to a silica gel (C-300, Wako Pure Chemical Industries, Ltd.) column (4.0 cm i.d. x 75 cm) packed with CHC13. The column was developed with linear gradient system composed of CHC13 (4.0 liters) and CHC13-MeOH,3 :2 (4.0 liters). The Shin Shikimeicho: Nihon Shikisai Co., Ltd., 1327-7 Higasi Ooizumi-cho, Nerima-ku, Tokyo, Japan. AUG. 1990 components of 6108 A group were successively eluted in the order of 6108 A4, A3, A2 and Ax. Each fraction was concentrated to give the crude powder. On the other hand, component B contained in the aqueous layer of the EtOAcextraction was extracted with an equal volume of BuOHand the extract was concentrated to give an oily residue. The oily residue was subjected to silica gel chromatography (Wako C-300, column: 3 cm i.d. x 30cm). The column was developed with linear gradient system composed of CHC13-MeOH,5 : 1 (1.0 liter) and CHC13-MeOH, 3 : 2 (1.0 liter). The active eluate was concentrated to give crude powder which was loaded on a column (3 cm i.d. x 30 cm) packed with Toyopearl HW-40(Tosoh Co., Ltd.) and developed with MeOH. The active fraction was concentrated in vacuo to give crude B. The purification of each crude powder was achieved by preparative HPLCusing a packed column (Develosil ODS-10, 20/250, Nomura Chemical Co., Ltd.) and TRI-ROTAR-V system (Jasco) with 0.01 m borate buffer (pH7.0) as solvent A and 80% CH3CNas solvent B at a flow rate of 16ml/minute. The solvent system A-B (55:45), (45:55) and (60:40) were applied for the separation of 6108 A1 and A2, A3 and A4, and B, respectively. The UVabsorbance of the eluate was monitored at 240 nmusing a spectrophotometer (UVIDEC-fOO-V, Jasco) equipped with a preparative cell (Jasco).
Isolation and Purification of CompoundsC and D
From the fermentation broth cultured with ST-7 medium, the EtOAcextract containing components A2, A3, A4 and D was obtained by the same procedures described for the extraction of compoundAx. The EtOAc extract (26 liters) was back extracted with dil HC1 (13 liters, pH 3.0) and the aqueous layer adjusted to pH 9.5 was reextracted with EtOAc(13 liters). The washed extract was concentrated to give an oily residue. ComponentD was purified from the oily residue by the same procedure described for compoundA3. ComponentC in the aqueous layer of the initial EtOAcextraction was purified by the same procedures as those of compoundB except Toyopearl HW-40chromatography.
Measurement of MIC MICof the antibiotics was determined by the serial agar dilution method on Mueller-Hinton agar (MH) for bacteria except Campylobacter at 37°C for 1 8 hours, and on 5% horse blood-supplemented MHfor Campylobacter sp. at 37°C for 48 hours.
Acute Toxicity in Mice LD50 values of antibiotics were determined by intraperitoneal or oral administration in female 5 weeks-old ICR mice purchased from Charles River Japan (Kanagawa). Each antibiotic was dissolved in DMSOand diluted to 5%of DMSOas a final concentration with 0.6% Tween-80 in saline. In the case of oral administration, antibiotics were suspended in 0.5% carboxymethyl cellulose in saline. Three mice per group were administrated intraperitoneally or orally at a volume 100 jul/10 g body weight and observed for a week. LD50values were determined by Litchfield and Wilcoxon method.
Protective Effect in Mice
In vivo antimicrobial activity was studied against experimental infection in 4-weeks-old ddY male mice (weight, 20±lg) . Ten mice in groups were intraperitoneally infected with 1,000 times LD50 (3.1 x 106cfu/mouse) of S. aureus 4970 suspended in 0.5ml of sterile saline containing 5% hog gastric mucin (Wako Pure Chemical, Osaka). One hour after challenge, mice were orally given a single administration of serial 2-fold doses of the test antibiotics which were suspended in 0.4% carboxymethyl cellulose containing 50mMphosphate buffer (pH 7.7). The ED50 (mg/kg) was determined by the probit method from survival rate on day 5 after infection.
